Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vortioxetine for Mood and Cognition in Frontotemporal Dementia
NCT06604520Phase 2Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Mar 2025
- Primary completion
- May 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vortioxetine in frontotemporal dementia (FTD), sponsored by Johns Hopkins University. Started Mar 2025; status: recruiting.
02
Drugs
vortioxetine
03
Conditions
frontotemporal dementia (FTD)
Beyond the preview
Go deeper on NCT06604520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06604520.